Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15229299 | 1.00 | APLNR (0.35) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL15229197 | 0.92 | APLNR (0.36) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL15229308 | 0.89 | CA2 (0.38) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL15229215 | 0.81 | SLC6A4 (0.34) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL31022566 | 0.81 | SLC6A4 (0.34) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL15229330 | 0.81 | SLC6A4 (0.34) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL15229099 | 0.81 | APLNR (0.36) | APLNRSLC6A4SLC6A2SLC6A3CA2 | |
| SCHEMBL16554196 | 0.80 | SLC6A4 (0.38) | APLNRSLC6A4SLC6A2SLC6A3CYP1A2 | |
| SCHEMBL15229246 | 0.80 | SLC6A4 (0.38) | APLNRSLC6A4SLC6A2SLC6A3CYP1A2 | |
| SCHEMBL31410509 | 0.79 | SLC6A4 (0.37) | APLNRSLC6A4SLC6A2SLC6A3CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3041471-A1 | COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES | F. Hoffmann-La Roche AG (CH) | 2016-07-13 | — | — | EP | disclosed |
| WO-2015032840-A1 | COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 2015-03-12 | — | — | WO | disclosed |
| EP-2820009-A1 | SERINE/THREONINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013130976-A1 | SERINE/THREONINE KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-09-06 | — | — | WO | disclosed |